VALNEVA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.448 EUR | +4.68% |
|
+9.74% | -27.40% |
| 06-28 | Valneva's Chikungunya Vaccine Secures Approval for Use in EU | MT |
| 06-26 | Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 39.36B | ||||||
| 38.52B | ||||||
| 30.74B | - | |||||
| 25.92B | ||||||
| 26.03B |
- Stock Market
- Equities
- VLA Stock
- AYJ Stock
- Charts Valneva
- Sector Chart
